StarTribune
Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Brainstorm Cell (NQ: BCLI )

0.3530 -0.0040 (-1.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 327,501
Open 0.3491
Bid (Size) 0.3451 (2)
Ask (Size) 0.3700 (12)
Prev. Close 0.3570
Today's Range 0.3428 - 0.3798
52wk Range 0.1340 - 2.133
Shares Outstanding 70,080,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga

Performance

YTD
+23.86%
+23.86%
1 Month
-29.40%
-29.40%
3 Month
-52.29%
-52.29%
6 Month
+23.86%
+23.86%
1 Year
-83.03%
-83.03%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
BCLI Stock Earnings: Brainstorm Cell Reported Results for Q1 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Brainstorm Cell: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BCLI Stock Earnings: Brainstorm Cell Beats EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting
Via Benzinga
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
BCLI DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - BCLI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm – BCLI
From The Rosen Law Firm PA
Via GlobeNewswire
BCLI FINAL DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm
From The Rosen Law Firm, P.A.
Via Business Wire
BRAINSTORM CELL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
Browse Business Sections
Latest Columns
Elsewhere in Business
  1. 5m
    US new-vehicle sales barely rose in the second quarter as buyers balked at still-high prices
  2. 15m
    Biden proposes new rule to protect 36 million workers from extreme heat
  3. 15m
    FDA approves a second Alzheimer's drug that can modestly slow disease
  4. 33m
    FTC says gig company Arise misled consumers about how much money they could make on its platform
  5. 53m
    California advances unique safety regulations for AI companies despite tech firm opposition
  6. 1h
    Diamond Shruumz microdosing candies may be linked to a death and nearly 50 illnesses, FDA says
  7. 1h
    US gives key approval to Atlantic Shores offshore wind farm in New Jersey
  8. 2h
    French candidates make hurried deals to try to stop far-right National Rally from leading government
  9. 2h
    Tesla sales fall for second straight quarter despite price cuts, but decline not as bad as expected
  10. 2h
    In wake of Supreme Court ruling, Biden administration tells doctors to provide emergency abortions
Most Read
  1. Minnesota health insurers seek premium hikes for individuals up to 12.75% • Business
  2. Apartment construction in the Twin Cities ground to a halt during June • Business
  3. C.H. Robinson makes unusual C-suite move to jump-start strategic planning, tech innovation • Business
  4. Uber, Lyft competitors confident about future in Twin Cities • Business
  5. Stock market today: Wall Street hits more records as Tesla zooms • Business

Business

Complete coverage of business news in the Twin Cities, Minnesota and elsewhere, including Fortune 500 Minnesota companies: UnitedHealth Group, Target, Best Buy, 3M, CHS, U.S. Bancorp, General Mills, C.H. Robinson, Land O’Lakes, Ecolab, Ameriprise Financial, Xcel Energy, Hormel Foods, Thrivent Financial, Polaris, Securian Financial Group, Fastenal and Patterson Cos.

© 2024 StarTribune. All rights reserved.